Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn if zolendric acid can prevent the anticipated deterioration of bone mass after antiviral treatment initiation for people that were recently diagnosed with H...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hadassah Medical Organization
Collaborators
NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more
NCT07187518 · Healthy, Osteopenia, and more
NCT06988033 · Osteopenia, Total Knee Arthroplasty
NCT06551155 · Osteoporosis, Osteopenia, and more
NCT06567054 · Healthy, Osteopenia, and more
Rambam Medical Center
Haifa
Hadassah Hebrew University Medical Center
Jerusalem
Sheba Medical Center
Ramat Gan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions